SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

NEULAND LABORATORIES

BSE: 524558 09 Sep 2025
Healthcare
₹ 14602
Neuland Laboratories Limited. specializes in Pharmaceuticals within the Healthcare sector.

NEULAND LABORATORIES - Share Price & Details

Market Cap
₹18,410
High /Low
18,100 / 10,060
Stock P/E
140.0
Book Value
₹1,188
Dividend Yield
0.08
ROCE
18.7
ROE
₹14.8
Face Value
10.0
PEG Ratio
2.95
EVEBITDA
₹71.0
Debt
157
CMP / FCF
137.0
Debt to equity
₹0.1
NP Ann
260
High price all time
18,100
Piotroski score
₹5.0
Graham Number
1,916
No. Eq. Shares
1.28
Net CF
₹44.4
Net profit
176
Price to book value
12.1
Interest Coverage
₹18.5
Low price all time
51.7
Industry PE
33.1
Reserves
₹1,512
Free Cash Flow
₹112

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
NEULAND LABORATORIES LTD.3006.09137.082927.5310.6818,410140.0
530019602.058.0595.00.261752236.0
Concord Biotech Limited2176.65425.652039.884.071685247.3

Peer Comparison Chart


About NEULAND LABORATORIES

Neuland Laboratories Limited., with Security Code 524558, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Neuland Laboratories - Vijay Kedia's Big Bets: 6 stocks surge up to 45% in 5 months — Do You Own Any?

(06 Sep 2025)
The stock has advanced 20% in FY26, rising from Rs 12077 to Rs 14457. Kedia owns a 1% stake, amounting to Rs 188 crore in value. Neuland...
Read more →

Buy, Sell or Hold: Nuvama initiates coverage on Neuland Laboratories; Motilal Oswal maintains buy on L&T F

(04 Sep 2025)
Brokerages remain positive on select mid-cap stocks. Nuvama initiated coverage on Neuland Laboratories with a Buy rating, citing strong...
Read more →

Pharma stock up 37% in 6 mths; Nuvama initiates with 'Buy', eyes 29% gains

(04 Sep 2025)
Nuvama on Neuland Laboratories: Shares of pharmaceutical company Neuland Laboratories may stay in focus after domestic brokerage Nuvama...
Read more →

Neuland Laboratories Opens Special Window for Physical Share Transfers

(03 Sep 2025)
Neuland Laboratories Ltd. ( ($IN:NEULANDLAB) ) has issued an announcement. Neuland Laboratories Ltd. has announced a special window for the...
Read more →

Individual investors are Neuland Laboratories Limited's (NSE:NEULANDLAB) biggest owners and were hit after market cap dropped ₹8.7b

(29 Aug 2025)
Key Insights Neuland Laboratories' significant individual investors ownership suggests that the key decisions are...
Read more →

Neuland Labs Appoints Dr. Ravi Shankar Gopinath as Independent Director

(26 Aug 2025)
The Board of Directors of Neuland Laboratories Limited has approved the appointment of Dr. Ravi Shankar Gopinath as an Independent Director,...
Read more →

Company Updates